Travere Therapeutics
TVTX
TVTX
149 hedge funds and large institutions have $1.56B invested in Travere Therapeutics in 2021 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 57 increasing their positions, 37 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
149
Holders Change
+12
Holders Change %
+8.76%
% of All Funds
2.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
37
Increased
57
Reduced
37
Closed
23
Calls
$3.07M
Puts
$2.76M
Net Calls
+$310K
Net Calls Change
+$1.29M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$60.9M |
| 2 |
AC
Armistice Capital
New York
|
+$58.8M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$42.4M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$26.4M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$24.6M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$23.6M |
| 2 |
SCM
Scopia Capital Management
New York
|
-$20.2M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$13.8M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$12.9M |
| 5 |
Millennium Management
New York
|
-$7.28M |
